139 related articles for article (PubMed ID: 16607840)
1. [How protective is the immunization against viral hepatitis B prospectively? Seroprevalence study on viral hepatitis B infection].
Bocşan IS; Gocan G; Ursu L; Brumboiu MI; Soşa I; Simionca L; Sava A; Olaru O; Păştina I
Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):124-30. PubMed ID: 16607840
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
3. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
Su FH; Chen JD; Cheng SH; Lin CH; Liu YH; Chu FY
J Med Virol; 2007 Feb; 79(2):138-43. PubMed ID: 17177303
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of hepatitis B infection in the Turkish population in Northern Cyprus.
Kurugöl Z; Koturoğlu G; Akşit S; Ozacar T; ; Kayimbaşoğlu S; Ozbalikçi S; Erçal G; Güllüelli E; Bakkaloğlu F; Doğan E; Garabli H; Erçal H; Mert C
Turk J Pediatr; 2009; 51(2):120-6. PubMed ID: 19480322
[TBL] [Abstract][Full Text] [Related]
6. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
Amini S; Mahmoodi MF; Andalibi S; Solati AA
J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
[TBL] [Abstract][Full Text] [Related]
7. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
[TBL] [Abstract][Full Text] [Related]
8. Viral hepatitis in Bucharest.
Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
[TBL] [Abstract][Full Text] [Related]
9. [Study on the variations of hepatitis B virus status among people having received hepatitis B vaccine].
Shen LP; Yang JY; Mo ZJ; Li RC; Li YP; Wei ZL; Dong YH; Zhou KJ; Wei SC; Fang KX; Yu T; Zhang WY; Zhang Y; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jul; 28(7):659-62. PubMed ID: 18069553
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
[TBL] [Abstract][Full Text] [Related]
11. [Are teenagers immunized in infancy still protected against hepatitis B?].
Pokorska-Lis M; Marczyńska M
Przegl Lek; 2010; 67(1):13-7. PubMed ID: 20509565
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of anti-HAV antibodies in Warsaw population].
Janaszek-Seydlitz W; Bucholc B; Wiatrzyk A
Przegl Epidemiol; 2007; 61(4):675-82. PubMed ID: 18572499
[TBL] [Abstract][Full Text] [Related]
13. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
14. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
15. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
[TBL] [Abstract][Full Text] [Related]
16. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization.
Chongsrisawat V; Yoocharoen P; Theamboonlers A; Tharmaphornpilas P; Warinsathien P; Sinlaparatsamee S; Paupunwatana S; Chaiear K; Khwanjaipanich S; Poovorawan Y
Trop Med Int Health; 2006 Oct; 11(10):1496-502. PubMed ID: 17002723
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
19. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
20. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
